Type 1 Diabetes is Preventable
A versatile human genome engineering platform is a reality, paving the way for the modification of disease-causing genes and helping to prevent certain metabolic conditions.
For a look ahead, Thomson Reuters analysts consulted the Web of Science and Derwent World Patents Index to identify rapid progress and emergent trends in scientific research and technological innovation, gauging the advances most likely to affect health and the quality of life in the next decade.
Thanks to ever-increasing knowledge regarding the molecular action and expression of genes and how these processes can be physically manipulated, the idea of disease prevention will be fundamentally altered.
Like type 2 diabetes, type 1 diabetes and other metabolic conditions such as muscular dystrophy will be preventable in 2025, but not by diet and exercise. Advancements in ribonucleic acid-guided (RNA-guided) engineering used for specialist sequence synthesis will be so much more sophisticated that a human genome engineering platform will exist. The pillar biological molecules of life on earth: RNA, DNA and proteins, and the roles they play, will be understood much more clearly in the next decade.
The in-depth operations of RNA, the main pathways from DNA to proteins, and proteins, the cell’s worker bees that carry out various catalytic and structural functions, will be demystified. The RNA/DNA process of passing inherited genetic information from one generation to the next will be clear. Increased knowledge of these biological pillars will make genomic-editing-and-repairing DNA a reality in humans, not just in bacteria and mice.
Also a reality will be the patenting of organisms and partial DNA segments, thereby complicating the landscape of who owns rights to what and where the line between nature and commerce exists.
The human genome engineering platform will pave the way for the modification of disease-causing genes in humans, leading to the prevention of type I diabetes, among other ailments.
RNA-Guided Human Genome Engineering in scientific literature points to emerging research front
Recombinant DNA Technology leads all areas of genetic engineering patenting
Note to Editors and Writers: For images and other resources, please visit our Editorial Resources page.
The data and citation records included in this report are from Thomson Reuters Web of ScienceTM. Web of ScienceTM is a registered trademark of Thomson Reuters. All rights reserved.